세계 인공 혈관 시장 규모는 2024년 20억 달러에 달했습니다. 향후 IMARC Group은 2033년에는 33억 달러에 도달하여 2025년부터 2033년까지 5.42%의 연평균 성장률(CAGR)을 기록할 것으로 예측하고 있습니다. 교통 사고 및 외상 사망자 수 증가, 의료 관광에 대한 관심 증가, 특히 노인층의 수술 건수 증가 등이 시장을 이끄는 주요 요인으로 작용할 것으로 예상됩니다.
인공 혈관은 인체에서 손상되거나 병든 혈관의 교체, 우회, 기능 회복에 사용되는 의료기기입니다. 인공 도관으로서 혈액의 흐름을 촉진하여 중요한 장기나 조직에 충분한 혈액이 공급될 수 있도록 합니다. 다크론이나 테프론과 같은 합성 고분자나 환자나 기증자로부터 채취한 정맥 부문과 같은 생물학적 재료 등 다양한 재료로 만들 수 있습니다. 관상동맥 우회술(CABG), 말초동맥우회술, 혈액투석 접근과 같은 수술에 일반적으로 사용됩니다.
교통사고 사망자 증가와 외상 사례의 확대가 전 세계적으로 인공 혈관 수요를 견인하고 있습니다. 또한, 의료 관광에 대한 관심이 높아지면서 사람들은 인공 혈관 수술을 포함한 전문적인 치료를 받기 위해 의료 시스템이 발달한 국가를 방문하고 있습니다. 또한, 수술 건수의 증가와 의료 장애에 취약한 전 세계 노인 인구의 증가는 시장에 긍정적인 영향을 미치고 있습니다. 이와는 별도로, 혈관 질환의 조기 진단 및 치료로 이어지는 예방 의료에 대한 관심이 높아짐에 따라 선제적 조치로서 인공 혈관의 필요성이 대두되고 있습니다. 또한, 보다 신속하고 편리한 수술을 제공하는 외래 수술 센터의 증가는 시장에 밝은 전망을 가져오고 있습니다.
생활습관병 증가
인공 혈관에 대한 수요를 촉진하는 주요 요인 중 하나는 비만과 당뇨병과 같은 생활습관병의 급증입니다. 이러한 질환은 이식 수술이 필요한 혈관 질환의 발병 위험을 크게 증가시킵니다. 생활습관병이 계속 증가함에 따라 관련 혈관 합병증을 관리하는 인공 혈관에 대한 수요는 크게 증가할 것으로 보입니다.
일반 시민의 의식과 교육 강화
혈관 질환과 그 치료법에 대한 대중의 인식이 높아지면서 인공 혈관에 대한 수요도 증가하고 있습니다. 공중보건 캠페인, 교육 프로그램, 디지털 플랫폼은 혈관 질환의 위험성과 조기 진단 및 치료의 중요성에 대해 사람들을 교육하고 있습니다. 이러한 인식의 증가로 인해 더 많은 사람들이 의료 자문을 구하고 있으며, 그 결과 인공 혈관 수술 건수가 증가하고 있습니다.
증가하는 규제 당국의 승인 및 상환 정책
우호적인 규제 당국의 승인 및 상환 정책은 인공 혈관 시장의 견인차 역할을 하고 있습니다. 많은 국가의 규제 기관은 인공 혈관을 포함한 새로운 의료기기의 승인을 위해 엄격하면서도 명확한 경로를 마련하고 있습니다. 일단 승인되면, 이러한 제품은 의료 시설에서 쉽게 채택될 수 있습니다. 또한, 종합적인 보험급여 정책은 환자들이 이러한 첨단 치료법을 경제적으로 선택할 수 있도록 하여 시장에서 인공 혈관에 대한 수요를 더욱 증가시키고 있습니다.
The global vascular grafts market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033. The increasing number of fatal road accidents and trauma cases, rising inclination towards medical tourism, and the growing number of surgical procedures, especially among the geriatric population, are some of the major factors propelling the market.
Vascular grafts are medical devices used to replace, bypass, or restore functionality to damaged or diseased blood vessels in the human body. They serve as artificial conduits that facilitate blood flow and ensure that vital organs and tissues receive adequate blood supply. They can be made from various materials, including synthetic polymers like dacron and teflon or biological materials like vein segments harvested from the patient or a donor. They are commonly used in surgical procedures, such as coronary artery bypass grafting (CABG), peripheral artery bypass, and hemodialysis access.
The increasing number of fatal road accidents and the expanding number of trauma cases are driving the demand for vascular grafts around the world. Moreover, the rising inclination towards medical tourism, wherein people are traveling to countries with advanced healthcare systems for specialized treatments, including vascular graft surgeries, is favoring the growth of the market. In addition, the growing number of surgical procedures and the rising global geriatric population, which is more susceptible to medical disorders, are influencing the market positively. Apart from this, the increasing focus on preventive healthcare, which leads to early diagnosis and treatment of vascular conditions, is catalyzing the need for vascular grafts as a preemptive measure. Furthermore, the growing number of ambulatory surgical centers, which offer quicker and more convenient surgical procedures, are creating a positive outlook for the market.
Increase in prevalence of lifestyle diseases
One of the primary factors that are driving the demand for vascular grafts is the surging prevalence of lifestyle-related diseases like obesity and diabetes. These conditions significantly elevate the risk of developing vascular problems that may necessitate graft surgeries. As lifestyle diseases continue to surge, the requirement for vascular grafts to manage associated vascular complications is likely to grow substantially.
Rise in public awareness and education
Increasing public awareness about vascular diseases and the available treatment options is also catalyzing thee demand for vascular grafts. Public health campaigns, educational programs, and digital platforms are educating people about the risks of vascular conditions and the importance of early diagnosis and treatment. This heightened awareness is leading to more people seeking medical advice and, consequently, increasing the number of vascular graft surgeries being performed.
Growing regulatory approvals and reimbursement policies
Favorable regulatory approvals and reimbursement policies play a crucial role in driving the market for vascular grafts. Regulatory bodies of numerous countries have stringent but clear pathways for the approval of new medical devices, including vascular grafts. Once approved, these products are more readily adopted by medical facilities. Additionally, comprehensive reimbursement policies make it financially feasible for patients to opt for these advanced treatments, further elevating the demand for vascular grafts in the market.
Endovascular stent grafts dominate the market
Hemodialysis access grafts serve a different purpose but are equally important in the field of medicine. They are used to provide reliable and durable vascular access for patients who require long-term hemodialysis, a treatment for kidney failure. Typically made of synthetic materials like PTFE (polytetrafluoroethylene), these grafts are surgically implanted to connect an artery to a vein, usually in the arm. Hemodialysis access grafts offer the advantage of immediate use, as opposed to AV fistulas that often require weeks to mature before they can be used for dialysis.
Polytetrafluoroethylene (PTFE) holds the largest share in the market
Polyester is another widely used synthetic material in the construction of vascular grafts, particularly in applications like aortic and peripheral vascular bypass surgeries. Often sold under the brand name Dacron, polyester vascular grafts have been used for several decades and have a well-established safety and efficacy profile. Polyester is known for its excellent mechanical properties, including tensile strength and durability, which makes it a preferred choice for long-term implantation. It also possesses good biocompatibility and allows for tissue ingrowth, which helps in anchoring the graft securely in place over time.
Cardiac aneurysm dominates the market
In the context of kidney failure, vascular grafts are commonly used to create a functional access point for hemodialysis. When a kidney fails of a patient to adequately filter blood, hemodialysis becomes necessary to remove waste products. Reliable vascular access is crucial for this process. Hemodialysis access grafts, often made from PTFE, are used to surgically connect an artery to a vein, usually in the arm. This connection, known as an arteriovenous (AV) graft, provides a high-flow circuit that facilitates efficient blood removal and return during dialysis sessions. These grafts are particularly useful for patients who cannot use an arteriovenous fistula, either due to poor vein quality or other medical considerations.
Hospitals hold the largest share in the market
Ambulatory surgical centers (ASCs) also serve as significant end users of vascular grafts, although their scope may be more limited as compared to hospitals. ASCs are healthcare facilities wherein surgeries that do not require an overnight hospital stay are performed. Due to advancements in minimally invasive surgical (MIS) techniques, certain procedures involving vascular grafts, such as some types of endovascular stent placements, can now be conducted in these settings. ASCs offer the advantage of quicker patient turnover, lower cost, and a more streamlined patient experience.
North America exhibits a clear dominance, accounting for the largest vascular grafts market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The surging prevalence of diabetes among the masses represents one of the primary factors bolstering the market growth in the North American region. Moreover, the rising adoption of cutting-edge diagnostic technologies like AI and advanced imaging is contributing to the market growth in the region. Besides this, the growing preference for MI surgeries is influencing the market positively.
The leading companies are developing bioengineered and drug-eluting grafts that aim to mitigate these drawbacks by incorporating living cells or biological molecules to improve biocompatibility and encourage tissue integration. They are also coated with pharmaceutical agents that are slowly released into the bloodstream, which reduces the risk of clot formation and vessel narrowing post-surgery. Moreover, key players are adopting the use of 3D printing technologies to create custom vascular grafts that match the specific anatomical needs of individual patients and reduce the risk of complications that can arise from ill-fitting grafts. They are also utilizing nanotechnology to offer unique mechanical and biological properties, which include better flexibility and reduced thrombogenicity.